ZOONO GROUP LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.072 AUD | +20.00% |
|
+2.86% | +63.64% |
| Apr. 23 | Zoono Group's Exclusive Agent OSY Signs First Major UK Client; Shares Up 18% | MT |
| Mar. 26 | Evolution Capital, OSY Group to Underwrite Zoono Group's AU$2.9 Million Rights Issue | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Zoono Group Limited is an Australia-based global biotech company that develops, manufactures and distributes a suite of antimicrobial solutions in multiple countries. The Company produces sprays, wipes and foams suited for skin care, surface sanitizers and mold remediation treatments. Its products are based on the ZOONO molecule, an antimicrobial molecule that bonds to any surface and kills pathogens including bacteria, viruses, algae, fungi and mold. The Company markets its products in various countries, including Australasia, Asia, United States, India, United Kingdom and Europe. Its subsidiaries include Zoono Group Limited (NZ), Zoono Limited, Zoono Holdings Limited (UK), Zoono EU Limited, Zoono (Shanghai) Biotech Co. Limited, Zoono Holdings USA LLC and Zoono South Africa (Pty) Ltd.
Sector
Personal Products
Calendar
2024-08-21
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +63.64% | 7.01M | |
| +10.21% | 379B | |
| +1.61% | 120B | |
| +11.13% | 72.61B | |
| -15.04% | 63.19B | |
| +1.83% | 52.85B | |
| -10.15% | 37.49B | |
| +1.40% | 32.93B | |
| +5.32% | 16.61B | |
| +4.17% | 14.54B |
- Stock Market
- Equities
- ZNO Stock
- News Zoono Group Limited
- Zoono Group Appoints CEO
